��ժҪ��Ϣ

[an error occurred while processing this directive]

��Ƥ��Բ�ѧ��־ 2006, 32(3) 179-181 DOI: ISSN: 2096-5540 CN: 32-1880/R

��Ŀ¼ | ��Ŀ¼ | �� | �߼�� [��ӡ��ҳ] [�ر�]

��

	��չ��

	��Ϣ
	Supporting info
	PDFȫ��
	[HTMLȫ��]
	�ο��
	��뷴��
	�ѱ��Ƽ��
	��ҵ��
	��ù��
	��ñ��
	Email Alert
	��·��
	��Ϣ
	��Ĺؼ��
	��м��
	ϸ��
	��
	��
	��ѧ��
	��ɭ
	��ά��
	PubMed
	Article by ZHANG Zheng-zhong
	Article by ZHANG Xue-jun
	Article by YANG Sen
	Article by SUI Wei-chi

��м��ϸ��

��¹, ��ѧ��¹, ��ɭ¹, ��ά��²

1. ��ҽ�ƴ�ѧƤ��о��һ��ҽԺƤ�� Ϸ� 230022;
2. �Ĵ�ʡ�ϳ��д��ҽѧԺ��ҽԺƤ��Բ��

ժҪ��

��м��һ��Ա�Ƥ��γ�ϸ��쳣��ͽǻ��ȫΪ��Ҫ��ı��Ը��֢��Ƥ��Ƥϸ��Ƥ��ƽ��ȶ��Ҫ��,��Ƥϸ��ֳ��ء��м��д��ϸ��쳣��Ϊ��,��м��ϸ��ػ��źŴ��۵��ٴ�Ӧ�÷��ȡ�õ�һЩ��չ��

�ؼ���� м�� ϸ��

Psoriasis and Apoptosis

Departmrnt of Dermatology, First Affiliated Hospital of Anhui Medical University, Hefei 230022, China

Abstract:

Psoriasis is a palindromic,chronic inflammatory dermatosis characterized by abnormal proliferation and parakeratosis of keratinocytes. The apoptosis of epidermal keratinocytes plays an important role in maintaining the balance of skin development and refreshment, and closely relates with the propagation of these cells. Abnormal apoptosis is present in psoriasis. The article reviews some progresses in the research of characteristics of, related genes and signal transduction in psoriatic cell apoptosis, as well as in the clinical usage of the theories in recent years.

Keywords: Psoriasis Apoptosis

�ո�� 2005-10-09 �޻�� ��淢��

DOI:

��Ŀ:

ͨѶ��:

��߼��:

�ο��ף�

[1] Laporte M,Galand P,Fokan D,et al.Apoptosis in established and healing psoriasis.Dermatology,2000,200:314-316.
[2] Bianchi L,Farrace MG,Nini G,et al.Abnormal Bcl-2 and "tissue"transglutaminase expression in psoriatic skin.J Invest Dermatol,1994,103:829-833.
[3] Wrone-Smith T,Johnson T,Nelson B,et al.Discordant expression of Bcl-x and Bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo.Am J Pathol,1995,146:1079-1088.
[4] Kanerva L.Electron microscopy of the effects of dithranol on healthy and on psoriatic skin.Am J Dermatopathol,1990,12:51.
[5] Kawashima K,Doi H,Ito Y,et al.Evaluation of cell death and proliferation in psoriatic epidermis.J Dermatol Sci,2004,35:207.
[6] Yamamoto T,Nishioka K.Alteration of the expression of Bcl-2,Bcl-x,Bax,Fas,and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.Skin Pharmacol Appl Skin Physiol,2003,16:50-58.
[7] Kocak M,Bozdogan O,Erkek E,et al.Examination of Bcl-2,Bcl-X and bax protein expression in psoriasis.Int J Dermatol,2003,42:789-793.
[8] Yildiz L,Baris S,Senturk N,et al.Overexpression of bcl-2 in lymphocytes of psoriatic skin.J Eur Acad Dermatol Venereol,2003,17:538-540.
[9] Takahashi H,Manabe A,Ishida-Yamamoto A,et al.Aberrant expression of apoptosis-related molecules in psoriatic epidermis.J Dermatol Sci,2002,28:187-197.
[10] Chiarugi V,Ruggiero M.Role of three cancer "master genes" p53,bcl2 and c-myc on the apoptotic process.Tumori,1996,82:205.
[11] Heenen M,Laporte M,Noel JC,et al.Methotrexate induces apoptotic cell death in human keratinocytes.Arch Dermatol Res,1998,290:240-245.
[12] Banno T,Gazel A,Blumenberg M.Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling.I Biol Chem,2004,279:32633.
[13] Jost M,Class R,Kari C,et al.A central role of Bcl-X(L) in the regulation of keratinocyte survival by autocrine EGFR ligands.J Invest Dermatol,1999,112:443-449.
[14] Tomkova H,Fujimoto W,Arata J.Expression pattern of the bcl-2 homologous protein bad in normal skin,psoriasis vulgaris and keratinocytic tumors.J Dermatol Sci,2000,22:132-137.
[15] Waring P,Mullbacher A.Cell death induced by the Fas/Fas ligand pathway and its role in pathology.Immunol Cell Biol,1999,77:312-317.
[16] Cataisson C,Joseloff E,Murillas R,et al.Activation of cutaneous protein kinase C alpha induces keratinocyte apoptosis and intraepidermal inflammation by independent signaling pathways.J Immunol,2003,171:2703-2713.
[17] Chen SH,Arany I,Apisarnthanarax N,et al.Response of keratinocytes from normal and psoriatic epidermis to interferon-gamma differs in the expression of zinc-alpha (2)-glycoprotein and cathepsin D.FASEB J,2000,14:565-571.
[18] Santamaria AB,Davis DW,Nghiem DX,et al.p53 and Fas ligand are required for psoralen and UVA-induced apoptosis in mouse epidermal cells.Cell Death Differ,2002,9:549-560.
[19] Deng H,Yan CL,Hu Y,et al.Photochemotherapy inhibits angiogenesis and induces apoptosis of endothelial cells in vitro.Photodermatol Photoimmunol Photomed,2004,20:191-199.
[20] Sugie N,Fujii N,Danno K.Cyclosporin-A suppresses p53-dependent repair DNA synthesis and apoptosis following ultraviolet-B irradiation.Photodermatol Photoimmunol Photomed,2002,18:163.
[21] Smit JV,de Jong EM,van Hooijdonk CA,et al.Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation,and improves differentiation in lesional skin.J Am Acad Dermatol,2004,51:257.
[22] Fukuya Y,Higaki M,Higaki Y,et al.Effect of vitamin D3 on the increased expression of Bcl-xL in psoriasis.Arch Dermatol Res,2002,293:620-625.
[23] Lippens S,Kockx M,Denecker G,et al.Vitamin D3 induces caspase-14 expression in psoriatic lesions and enhances caspase-14 processing in organotypic skin cultures.Am J Pathol,2004,165:833.
[24] McGill A,Frank A,Emmett N,et al The anti-psoriatic drug anthralin accumulates in keratinocyte mitochondria,dissipates mitochondrial membrane potential,and induces apoptosis through a pathway dependent on respiratory competent mitochondria.FASEB J,2005,19:1012-1014.
[25] Heenen M,Laporte M,Noel JC,et al.Methotrexate induces apoptotic cell death in human keratinocytes.Arch Dermatol Res,1998,290:240-245.